Charles River Laboratories Overview
- Founded
- 1947
- Status
- Public
- Employees
- 20,000
- Stock Symbol
- CRL
- Investments
- 52
- Share Price
- $266.47
- (As of Monday Closing)
Charles River Laboratories General Information
Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Contact Information
Website
www.criver.com
Formerly Known As
Charles River Foundation, Charles River Breeding Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Stock Exchange
NYS
Primary Office
- 251 Ballardvale Street
- Wilmington, MA 01887
- United States
+1 (781) 000-0000
Charles River Laboratories Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $266.47 | $278.00 | $261.82 - $460.21 | $14B | 50.5M | 472K | $7.77 |
Charles River Laboratories Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2021 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 22,009,156 | 22,009,156 | 14,400,964 | 9,380,543 |
| Revenue | 3,540,160 | 3,540,160 | 2,923,933 | 2,621,226 |
| EBITDA | 819,508 | 819,508 | 767,637 | 561,539 |
| Net Income | 390,982 | 390,982 | 364,304 | 252,019 |
| Total Assets | 7,024,292 | 7,024,292 | 5,490,831 | 4,692,790 |
| Total Debt | 2,952,598 | 2,952,598 | 2,160,054 | 2,024,820 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Charles River Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Charles River Laboratories‘s full profile, request access.
Request a free trialCharles River Laboratories Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The
Drug Discovery
Wilmington, MA
20,000
As of 2021
00000
00000000000
00000
0000000
ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
0000 000000000
Ann Arbor, MI
00000
As of 0000
00 000000
000000
consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
0000 000000000
Hyderabad, India
0000
As of 0000
0000
00
0000-00-00
00000000000
0000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCharles River Laboratories Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Covance | Private Equity-Backed | Ann Arbor, MI | 00000 | 00 000000 | ||
| 000000 | Private Equity-Backed | Hyderabad, India | 0000 | 0000 | 00000000000 | 0000 |
| 000000000 | Private Equity-Backed | Montreal, Canada | 000 | 000000000000 | ||
| 0000 000000 | Formerly PE-Backed | Shanghai, China | 00000 | 00.000 | 000000000 | 00.000 |
| 0000000-000000 | Private Equity-Backed | San Diego, CA | 0000 | 000000000000 |
Charles River Laboratories Patents
Charles River Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210079066-A1 | Radically diverse human antibody library | Pending | 18-Dec-2017 | 0000000000 | |
| US-20190086397-A1 | Cho host cell protein assay | Pending | 20-Sep-2017 | 0000000000 | |
| GB-201704965-D0 | Pharmaceutical compounds | Ceased | 28-Mar-2017 | 0000000000 | |
| US-20210101887-A1 | Isoindolinone inhibitors of the mdm2-p53 interaction and process for making them | Pending | 28-Mar-2017 | 0000000000 | |
| JP-2020515546-A | Isoindolinone inhibitors of mdm2-p53 interaction and process for making the same | Pending | 28-Mar-2017 | C07D405/06 |
Charles River Laboratories Executive Team (51)
Charles River Laboratories Board Members (17)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0. 00000 | Charles River Laboratories | Board Member | 000 0000 |
| 0000000 00000000 00.0 | Charles River Laboratories | Board Member | 000 0000 |
| 000000 00000 | Charles River Laboratories | Board Member | 000 0000 |
| 000000 0000000 | Charles River Laboratories | Board Member | 000 0000 |
| 000000 00000 00.0 | Self | Board Member | 000 0000 |
Charles River Laboratories Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCharles River Laboratories Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Charles River Laboratories‘s full profile, request access.
Request a free trialCharles River Laboratories Investments & Acquisitions (52)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000.000 | 31-Dec-2021 | 00000 0000 | 00000 | Drug Discovery | |
| 0000000000 | 22-Nov-2021 | 00000 0000 | 000.00 | Biotechnology | |
| 000000 000000 | 28-Jun-2021 | 0000000000 | 00000 | Other Pharmaceuticals and Biotechnology | 00000 000 |
| 0000000000 | 30-Mar-2021 | 0000000000 | 000.00 | Discovery Tools (Healthcare) | 00000 000 |
| Cognate Bioservices | 29-Mar-2021 | Merger/Acquisition | 00000 | BPO/Outsource Services | 00000 000 |
Charles River Laboratories Subsidiaries (8)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Vigene Biosciences | Other Pharmaceuticals and Biotechnology | Rockville, MD | 2012 |
| 00000000000 000 | Biotechnology | South San Francisco, CA | 0000 |
| 0000000000 | Discovery Tools (Healthcare) | Chinley, United Kingdom | 0000 |
| 00000000 | Biotechnology | Worcester, MA | 0000 |
| 0000000 0000000000 | BPO/Outsource Services | Memphis, TN | 0000 |
Charles River Laboratories Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 00000 0000 | 30-Oct-2006 | 000000000000000000 | 000.00 | Completed |
|
| Charles River Proteomic Services | 02-Oct-2002 | Joint Venture | 000 | Completed |
|